[CRVS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -79.49%
YoY- -38.96%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -6,503 -7,873 -9,816 -14,831 -8,363 -8,297 -9,236 -20.90%
Tax -403 923 6,384 -225 -100 884 8 -
NP -6,503 -8,796 -16,200 -14,831 -8,263 -9,181 -9,236 -20.90%
Tax Rate - - - - - - - -
Total Cost 6,503 8,796 16,200 14,831 8,263 9,181 9,236 -20.90%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.14 -0.19 -0.35 -0.32 -0.18 -0.20 -0.20 -21.21%
EPS Diluted -0.14 -0.19 -0.35 -0.32 -0.18 -0.20 -0.20 -21.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.